Variants in the WDR45 Gene Within the OPA-2 Locus Associate With Isolated X-Linked Optic Atrophy
Investigative Opthalmology & Visual Science · 2023
DOI: 10.1167/iovs.64.13.17 ↗At a glance
Journal article in Investigative Opthalmology & Visual Science, 2023. Written by Inbal Gazit and 12 co-authors. Institution: Department of Ophthalmology, Shamir Medical Center, Zerifin, Israel. Major MEDLINE topics: Autism Spectrum Disorder, Genetic Diseases, X-Linked, Optic Atrophy. Cited 3 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Purpose
To describe clinical and molecular findings of two families with X-linked optic atrophy and present two new pathogenic variants in the WDR45 gene.
Methods
Case series and molecular analysis of two families of Jewish Ashkenazi descent with early onset bilateral optic atrophy. Whole-exome sequencing (WES) and bioinformatic analysis were performed, followed by Sanger sequencing and segregation analysis.
Results
In both families, male siblings (three in family 1, two in family 2) had early-onset isolated bilateral optic atrophy. The sibling's healthy mother (and in the second family also one healthy sister) had a mild presentation, suggesting a carrier state and an X-linked inheritance pattern. All participants were otherwise healthy, apart from mild learning disabilities and autism spectrum disorder in two siblings of the second family. Variants in known optic atrophy genes were excluded. Analysis revealed a point variant in the WDR45 gene-a missense variant in the first family, NM_001029896.2:c.107C>A; NP_001025067.1:p.Pro36His (variant ID: 1704205), and a splice site variant in the second family, NM_001029896.2:c.236-1G>T; NP_009006.2:p.Val80Leu (variant ID: 1704204), located on Xp11.23 (OPA2 locus). Both variants are novel and predicted as pathogenic. In both families, the variant was seen with full segregation with the disease, occurring in all affected male participants and in one allele of the carrier females, as well as none of the healthy participants.
Conclusions
Among two families with isolated X-linked optic atrophy, molecular analysis revealed novel variants in the WDR45 gene in full segregation with the disease. This gene resides within the OPA2 locus, previously described to associate with X-linked optic atrophy. Taken together, these findings suggest that certain pathogenic variants in the WDR45 gene are associated with isolated X-linked optic atrophy.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Ophthalmology, Shamir Medical Center, Zerifin, Israel.
- Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- The Matlow's Ophthalmo-genetics Laboratory, Shamir Medical Center, Zerifin, Israel.
- Department of Ophthalmology, Edith Wolfson Medical Center, Holon, Israel.
- Institute of Medical Genetics, Wolfson Medical Center, Holon, Israel.
- The Genetic Institute of Maccabi Health Medicinal Organization, Tel Aviv, Israel.
Cite
APA
Gazit, I., Hecht, I., Weiner, C., Kotlyar, A., Almer, Z., Bakshi, E., Or, L., Volkov, H., Feldman, B., Maharshak, I., Michelson, M., Goldenberg-Cohen, N., & Pras, E. (2023). Variants in the WDR45 Gene Within the OPA-2 Locus Associate With Isolated X-Linked Optic Atrophy. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.64.13.17
Vancouver
Gazit I, Hecht I, Weiner C, Kotlyar A, Almer Z, Bakshi E, et al. Variants in the WDR45 Gene Within the OPA-2 Locus Associate With Isolated X-Linked Optic Atrophy. Investigative Opthalmology & Visual Science. 2023. doi:10.1167/iovs.64.13.17
BibTeX
@article{Gazit2023,
author = {Gazit, Inbal and Hecht, Idan and Weiner, Chen and Kotlyar, Alina and Almer, Zina and Bakshi, Erez and Or, Lior and Volkov, Hadas and Feldman, Barak and Maharshak, Idit and Michelson, Marina and Goldenberg-Cohen, Nitza and Pras, Eran},
title = {Variants in the WDR45 Gene Within the OPA-2 Locus Associate With Isolated X-Linked Optic Atrophy},
journal = {Investigative Opthalmology & Visual Science},
year = {2023},
doi = {10.1167/iovs.64.13.17}
}
EUVIMED